ERBB2 and neoplasm: This was confirmed by FISH which also showed obvious tumor heterogeneity with HER2 gene cluster amplification in the IHC 3+ areas, and dot amplification (HER2/CEP17 ratio = 3) in the IHC2+ components (Figure 3).